QIAGEN N.V. (QGEN) recently launched two new tools for designing and ordering custom solutions to support microbial analysis of bacterial, fungal and viral targets. These new tools should enable researchers to customize their assays and panels for use on the QIAcuity digital PCR (dPCR) system and any third-party next-generation sequencing (NGS) system. These customizable digital PCR assays will be available on QIAGEN’s GeneGlobe web portal. QGEN Stock’s Trend Following the NewsSubsequent to the news, QGEN's ...